LUNG Pulmonx
Pulmonx earnings company data as of 4:46 AM ET 10/15
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 11 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by LUNG's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $164K sold by 1 insider outside a trading plan
- $46K sold by 1 insider under 10b5-1 plans
-
Glendon E. French III CEOSale$80K 51,978 shares at $1.55 4.2% of stakeTraded Jun 1–2 Filed Jun 3
-
Glendon E. French III CEOSale$83K 58,368 shares at $1.43 4% of stakeTraded Mar 2 Filed Mar 4
-
Daniel P Florin DirectorPlanned sale$46K 23,321 shares at $1.99 20% of stakeTraded Dec 8, 2025 Filed Dec 9, 2025
Also filed in the last 12 months, not counted as buying or selling: 51 sales to cover taxes and 11 stock grants.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 1.01,1.02,2.03,3.02,9.01 | Filing Doc | |
| 8-K | 2.02 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.